Key result
Self-monitoring of blood pressure with telemonitoring and without telemonitoring reduced 12-month clinic systolic BP by 4.7 mmHg and 3.5 mmHg, respectively, compared to usual care.
Why the study?
Does self-monitoring of blood pressure, with or without telemonitoring, to guide antihypertensive medication titration improve clinic systolic blood pressure control compared to usual clinic-based care in patients with uncontrolled hypertension?
Does self-monitoring of blood pressure, with or without telemonitoring, to guide antihypertensive medication titration improve clinic systolic blood pressure control compared to usual clinic-based care in patients with uncontrolled hypertension?
Answers are grounded in this paper and cite their sources.
This editorial highlights that the TASMINH4 trial supports using patient self-monitored blood pressure, with or without telemonitoring, to guide antihypertensive titration in primary care to achieve better blood pressure control than usual clinic-based care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2019) conducted an editorial in Uncontrolled hypertension (n=1,182). Self-monitored blood pressure (with or without telemonitoring) to guide antihypertensive medication titration vs. Usual care (antihypertensive medication titration based on clinic BP measurements at GP discretion) was evaluated on Clinic systolic blood pressure at 12 months (MD -4.7 mmHg (telemonitoring vs usual care) and MD -3.5 mmHg (self-monitoring vs usual care), 95% CI 2.4-7.0). Self-monitoring of blood pressure with telemonitoring and without telemonitoring reduced 12-month clinic systolic BP by 4.7 mmHg and 3.5 mmHg, respectively, compared to usual care.
Synapse has enriched 10 related papers. Consider them for comparative context: